Molecular basis of GM1 gangliosidosis and Morquio disease, type B.: Structure-function studies of lysosomal β-galactosidase and the non-lysosomal β-galactosidase-like protein

被引:79
作者
Callahan, JW
机构
[1] Univ Toronto, Hosp Sick Children, Dept Pediat Lab Med, Res Inst, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Hosp Sick Children, Dept Pediat Lab Med, Genet Metab Lab, Toronto, ON M5G 1X8, Canada
[3] Univ Toronto, Dept Biochem, Toronto, ON M5G 1X8, Canada
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 1999年 / 1455卷 / 2-3期
基金
英国医学研究理事会;
关键词
GM1; gangliosidosis; Morquio disease; galactosialidosis; sialidosis; beta-galactosidase; cathepsin A; neuraminidase;
D O I
10.1016/S0925-4439(99)00075-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
GM1 gangliosidosis and Morquio B disease are distinct disorders both clinically and biochemically yet they arise from the same beta-galactosidase enzyme deficiency. On the other hand, galactosialidosis and sialidosis share common clinical and biochemical features, yet they arise from two separate enzyme deficiencies, namely, protective protein/cathepsin A and neuraminidase, respectively. However distinct, in practice these disorders overlap both clinically and biochemically so that easy discrimination between them is sometimes difficult. The principle reason for this may be found in the fact that these three enzymes form a unique complex in lysosomes that is required for their stability and posttranslational processing. In this review, I focus mainly on the primary and secondary beta-galactosidase deficiency states and offer some hypotheses to account for differences between GM1 gangliosidosis and Morquio B disease. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:85 / 103
页数:19
相关论文
共 115 条
  • [1] AhernRindell AJ, 1996, AM J MED GENET, V63, P340, DOI 10.1002/(SICI)1096-8628(19960517)63:2<340::AID-AJMG3>3.0.CO
  • [2] 2-X
  • [3] MORQUIO-LIKE SYNDROME WITH BETA GALACTOSIDASE DEFICIENCY AND NORMAL HEXOSAMINE SULFATASE ACTIVITY - MUCOPOLYSACCHARIDOSIS IVB
    ARBISSER, AI
    DONNELLY, KA
    SCOTT, CI
    DIFERRANTE, N
    SINGH, J
    STEVENSON, RE
    AYLESWORTH, AS
    HOWELL, RR
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1977, 1 (02): : 195 - 205
  • [4] Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis
    Bonten, E
    vanderSpoel, A
    Fornerod, M
    Grosveld, G
    dAzzo, A
    [J]. GENES & DEVELOPMENT, 1996, 10 (24) : 3156 - 3169
  • [5] BOUSTANY RM, 1993, AM J HUM GENET, V53, P881
  • [6] OLIGOSACCHARIDES DERIVED BY KERATANASE-II DIGESTION OF BOVINE ARTICULAR-CARTILAGE KERATAN SULFATES
    BROWN, GM
    HUCKERBY, TN
    NIEDUSZYNSKI, IA
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 224 (02): : 281 - 308
  • [7] OLIGOSACCHARIDES DERIVED FROM BOVINE ARTICULAR-CARTILAGE KERATAN SULFATES AFTER KERATANASE-II DIGESTION - IMPLICATIONS FOR KERATAN SULFATE STRUCTURAL FINGERPRINTING
    BROWN, GM
    HUCKERBY, TN
    MORRIS, HG
    ABRAM, BL
    NIEDUSZYNSKI, IA
    [J]. BIOCHEMISTRY, 1994, 33 (16) : 4836 - 4846
  • [8] SKELETAL KERATAN SULFATE STRUCTURAL-ANALYSIS USING KERATANASE-II DIGESTION FOLLOWED BY HIGH-PERFORMANCE ANION-EXCHANGE CHROMATOGRAPHY
    BROWN, GM
    NIEDUSZYNSKI, IA
    MORRIS, HG
    ABRAM, BL
    HUCKERBY, TN
    BLOCK, JA
    [J]. GLYCOBIOLOGY, 1995, 5 (03) : 311 - 317
  • [9] CALLAHAN JW, 1976, J NEUROCHEM, V26, P217
  • [10] CHAKRABORTY S, 1994, AM J HUM GENET, V54, P1004